|
Management
Leadership: Dr. Arthur DeCarlo, President and
CEO
Vice President for Business Development: Mr. David Jefferson
Vice President for Marketing: Dr.
Kathy Nugent
Secretary/Treasurer: Dwight Brisendine, Internal Financial Control
Services.
Director; Richard Furey, White,
Case LLP
Corporate Advisory Board:
Mr. Vinny
Jindal is Bonenta’s Chief Strategic Advisor. Mr. Jindal has an excellent understanding of the underlying
science and of the biotechnology industry having received two Masters of
Science degrees then going on to serve as a biotechnology analyst with Webush
Morgan Securities, and Lehman Brothers, then a Managing Director with ThinkEquity,
then a Principal with Boston Millenia Partners.
Mr. Sandy
White is a key member of our Board of Advisors. Mr. White has over 25 years of
broad pharmaceutical industry and technology commercialization experience. This
experience has resulted in a strong core competency in general management,
global corporate development/licensing, and technology commercialization.
Additional significant experience encompasses a variety of functions, including
research and development, investment banking, venture capital, regulatory
affairs, sales and marketing. Primary therapeutic/technical areas of knowledge
include biotechnology, oncology, ophthalmology, cardiology and virology. Prior
positions include CEO, President of BioCache Pharmaceuticals, Inc.; Vice President
of R&D/Commercial Development & Planning of Storz Ophthalmics, a
division of American Home Products; President/Business Leader of Integrated
Protein Technologies, a unit of Monsanto and CEO of the University of Alabama
at Birmingham Research Foundation. Experience at the Board of Director level
includes BioCache Pharmaceuticals and CropTech Corporation (Chairman). Sandy is
a current member of the management team and Board of Directors of Icon
Bioscience, Inc. He also serves as an advisor to Ramscor, Inc. He received a
degree in Biology from the University of Virginia where he was the recipient of
the Folkes Scholarship, a degree in Pharmacy from the Medical College of
Virginia and a Master of Business Administration degree from Virginia
Commonwealth University.
Mr.
Jonathan Nugent is another important member of Bonenta's Board of Advisors. Mr.
Nugent has significant experience in financial matters pertaining to
biotechnology, most recently as Vice President, Corporate Communications and
Investor Relations of the Birmingham-based public company BioCryst. Prior to
joining BioCryst, Mr. Nugent served as Senior Vice President and Director of
Investor Relations at Burns McClellan, Inc., the country's largest independent
healthcare public and investor relations firm. Working primarily in the
agency's New York office, Mr. Nugent provided senior counsel to companies
specializing in pharmaceutical discovery and development, drug delivery,
medical devices and diagnostics, as well as to advisory and investment firms
focusing on the biotechnology industry. He has extensive experience in
providing strategic guidance in the areas of financial, scientific and
regulatory communications, product launches, meetings before the FDA, IPO and
follow-on financings, U.S. and European investors and crisis and issues
management. Jon understands corporate financing as it pertains to biotechnology
and will add value to Bonenta through his advice as well as his relationships
with others in the biotechnology and financing industries.
Scientific Advisory Board:
Dr.
John M. Whitelock, Professor of Biomedical Engineering, U. of NSW, Australia
Dr. Ling Li, Torrey
Pines Institute for Molecular Studies, Port St. Lucie, Florida.
Dr. Patrick Hardigan,
Director Statistical Consulting, NSU, Florida
Dr. Nico Geurs,
Director Postgraduate Periodontics, UAB, Alabama
Dr. M. Renee' Chambers,
Assistant Prof., Neurosurgery, UAB, Alabama
|
